Cited by 34Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSchizophrenia research and treatment

A Double-Blind, Randomized, 26-Week Study Comparing the Cognitive and Psychomotor Effects and Efficacy of 75 mg (37.5 mg b.i.d.) Venlafaxine and 75 mg (25 mg Mane, 50 mg Nocte) Dothiepin in Elderly Patients with Moderate Major Depression Being Treated in General Practice

Open access
Trick, Leanne, Stanley, Neil, Rigney, Una, Hindmarch, Ian·2004·Journal of Psychopharmacology

Abstract

To investigate the efficacy and cognitive and psychomotor effects of venlafaxine and dothiepin in elderly patients with moderate major depression. A prospective, randomized, double-blind, parallel-group, active comparator controlled study was conducted. Eighty-eight patients (aged ≥ 60 years) were enrolled. Each patient received either venlafaxine (immediate release formulation) 37.5 mg twice per day or dothiepin 25 mg mane followed by 50 mg nocte for 26 weeks. Efficacy was assessed with the Montgomery-Asberg Depression Rating Scale and the Hamilton Depression Rating Scale. A psychometric test battery to assess cognitive function, activities of daily living and sleep consisted of Critical Flicker Fusion (CFF), Short-term Memory - Kim’s Game, Cognitive Failures Questionnaire, Milford Epworth Sleepiness Scale, Leeds Sleep Evaluation Questionnaire, and an Accident Scoring Questionnaire. Quality of Life Questionnaires (Short Form 36 and Quality of Life in Depression Scale) were also administered. Venlafaxine significantly ( p < 0.05) raised CFF scores compared to baseline but had no effect on any other measure. Dothiepin significantly ( p < 0.05) lowered CFF threshold, and increased ratings of both sedation and difficulty in waking. The results showed that venlafaxine at doses of 37.5 mg b.i.d. in elderly depressed patients is free from disruptive effects on cognitive function and psychomotor performance.

Integrity signals

Registry

Crossref · 10.1177/0269881104042622

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • After removing the venlafaxine versus dothiepin trial (Trick et al., 2004), SSRIs/SNRIs have a statistically significant greater effect on memory compared to TCAs (SMD 0.58; 95% CI 0.31-0.84; p < 0.00001; I2 = 0%).

    “when removing one study evaluating venlafaxine versus dothiepin (Trick et al., 2004), which appeared to be divergent from the other studies, I2 became 0% and the SMD rose to 0.58 (95% CI 0.31 to 0.84; p < 0.00001) in favor of SSRIs/SNRIs”

Cites

Flagged first, then by citations

1 of the 55 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Trick, L., Stanley, N., Rigney, U., & Hindmarch, I.
Affiliations
University of Surrey (GB)
Corresponding author
Trick, Leanne
Venue
Journal of Psychopharmacology
Published
2004-06
Volume
18
Issue
2
Pages
205-214
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2087216612
Cited by
34
References
55
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 5 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
1.88
Type
journal article
Language
en
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Durham Research Online (Durham University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
venlafaxine, dothiepin, geriatric depression, major depressive disorder, cognitive function, psychomotor performance, critical flicker fusion, sleepiness, sedation, quality of life, antidepressant efficacy, general practice
MeSH terms
Venlafaxine Hydrochloride, Aged, Cognition, Cyclohexanols, Depressive Disorder, Dizziness, Dothiepin, Double-Blind Method, Drug Administration Schedule, Female, Flicker Fusion, Humans, Disorders of Excessive Somnolence, Male, Narcolepsy, Nausea, Psychometrics, Psychomotor Performance, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review